Jasper Therapeutics (JSPR)
(Delayed Data from NSDQ)
$20.04 USD
+0.21 (1.06%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $20.14 +0.10 (0.50%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.08 | 0.00% |
Earnings Summary
For their last quarter, Jasper Therapeutics (JSPR) reported earnings of -$0.97 per share, beating the Zacks Consensus Estimate of $-1.09 per share. This reflects a positive earnings surprise of 11.01%. Look out for JSPR's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.08 per share, reflecting a year-over-year increase of 32.5%.
Earnings History
Price & Consensus
Zacks News for JSPR
Jasper Therapeutics (JSPR) Is a Great Choice for 'Trend' Investors, Here's Why
JSPR: What are Zacks experts saying now?
Zacks Private Portfolio Services